 |
    | | ||
 |
 | |||
 |
|
 | ||
 | ||||
|
|
  Cytomedix develops biologically active regenerative therapies for wound care, angiogenesis, and inflammation. Our goal is to harness the complex balance of essential life processes, functions and activities that mirror the potent therapeutic effects of the human body, to treat complex medical conditions. Read more about our company.  Cytomedix Appoints Patrick Vanek as Vice President of Operations Positive Data from Study of the AutoloGel System to Treat Complex Chronic Wounds Published in Ostomy Wound Management Read all press releases  The AutoloGel System harnesses the patient's natural healing processes with the delivery of a platelet releasate gel containing growth factors, cytokines and chemokines required for cell growth and formation of new tissue. Restoring the balance in the wound environment can transform a non healing wound to a wound that heals naturally. Continue > 
|
| ||
 |
  | |||
| © 2009 Cytomedix. All Rights Reserved. | Site Map | Terms & Conditions |